Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -148 | -42 | 4 | -1 | -46 |
| Accounts payable and accrued liabilities | 689 | 1,801 | 2,000 | -501 | 183 |
| Other Working Capital | 54 | 2,189 | 1,925 | -83 | -449 |
| Other Operating Activity | -2,457 | -5,002 | -5,504 | -4,709 | -915 |
| Operating Cash Flow | $-1,862 | $-1,055 | $-1,575 | $-5,294 | $-1,227 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -1,056 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 61 |
| Investing Cash Flow | $-1,056 | $N/A | $N/A | $N/A | $61 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -33 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | 0 | -370 | N/A |
| Common Stock Issued | 3,161 | 917 | 1,108 | 3,060 | 2,973 |
| Other Financing Activity | 0 | 0 | 0 | 748 | 382 |
| Financing Cash Flow | $3,127 | $917 | $1,108 | $3,439 | $3,355 |
| Exchange Rate Effect | 2 | -3 | 15 | 25 | 5 |
| Beginning Cash Position | 1 | 142 | 593 | 2,423 | 229 |
| End Cash Position | 212 | 1 | 142 | 593 | 2,423 |
| Net Cash Flow | $208 | $-138 | $-466 | $-1,855 | $2,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,862 | -1,055 | -1,575 | -5,294 | -1,227 |
| Capital Expenditure | -1,056 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,919 | -1,055 | -1,575 | -5,294 | -1,227 |